Century(SZ:300078) Sou Hu Cai Jing·2025-12-03 13:39Core Viewpoint - The company, Sichuang Medical Technology Co., Ltd., has undergone significant leadership changes, with the resignation of Chairman Xu Yiran and the appointment of Wei Naixu as the new chairman and legal representative, indicating a restructuring effort within the company's governance [1][2]. Leadership Changes - Xu Yiran resigned from his positions as Chairman, Strategic Decision Committee Chair, and Audit Committee member to facilitate governance optimization, while remaining a board member [1]. - Wei Naixu was elected as the new Chairman and legal representative of the company, with his term starting from the approval date of the board meeting [1]. - Wu Weibin was appointed as the new Deputy General Manager, with his term also starting from the same board meeting [1]. Shareholding and Control - Wei Naixu indirectly holds 20,732,440 shares (1.85% of total shares) through Cangnan Xinchuan and has control over 63,890,185 shares (5.72%) via Cangnan Xincheng, making him the actual controller of the company with a total of 83,471,940 shares (7.47%) after a pending share transfer [2]. - After the share transfer is completed, Wei Naixu will control a total of 147,362,125 shares (13.18% of total shares) [2]. Company Background - Sichuang Medical Technology Co., Ltd. was established in 2003 and listed on the Shenzhen Stock Exchange in April 2010, recognized as a leading provider of smart medical and IoT application solutions [5]. Financial Performance - The company has faced significant financial challenges, reporting continuous net profit losses over the past five years, with cumulative losses exceeding 3 billion yuan [6]. - In the latest financial report, the company achieved a revenue of 603.8 million yuan in the first three quarters, a year-on-year increase of 6.95%, but still reported a net loss of 4.762 million yuan [6].